GOLONGAN HIPEROSMOTIK
• GLYCEROL HAS BEEN FOUND TO BE EASILY TOLERATED ON ORAL USE WITHOUT ANY
SIDE-EFFECTS OR TOXIC SYMPTOMS.
• DOSE : 1-2 G/KG/DOSE ORALLY, REPEAT EVERY 5 HOURS WHEN REQUIRED
• CAMPUR DENGAN MINUMAN RASA JERUK (1:1.5)
• LANGSUNG MINUM SEMUA
MANNITOL
• HYPEROSMOTIC AGENT
• MODE OF ACTION
• INCREASES PLASMA OSMOLALITY; DEHYDRATES VITREOUS BODY. PRODUCES A
RAPID (30 MINUTES) BUT TEMPORARY (6 HOURS) DROP IN INTRAOCULAR
PRESSURE.
• INDICATIONS
• ACUTE CLOSED-ANGLE GLAUCOMA UNRESPONSIVE TO CONVENTIONAL
TREATMENT
• ADVERSE EFFECTS
• ADVERSE EFFECTS ARE GENERALLY INFREQUENT
• FLUID AND/OR ELECTROLYTE SHIFT CAN PRODUCE PULMONARY CONGESTION,
ACIDOSIS, ELECTROLYTE LOSS, DRY MOUTH, THIRST, OEDEMA, HEADACHE,
BLURRED VISION, SEIZURES AND HEART FAILURE.
• DOSAGE – MANNITOL
• ADULT, IV 1–2 G/KG (5–10 ML/KG OF 20% SOLUTION) OVER 30 MINUTES.
MANNITOL
• ADMINISTRATION ADVICE
• MANNITOL CRYSTALLISES AT LOW TEMPERATURES (ESPECIALLY 20% SOLUTION);
REDISSOLVE BY WARMING IN HOT WATER AND SHAKING VIGOROUSLY; ALLOW
TO COOL TO BODY TEMPERATURE BEFORE GIVING VIA INFUSION SET WITH
FILTER.
• PRACTICE POINTS
• MANNITOL PRODUCES A MARKED OSMOTIC DIURESIS; URINARY
CATHETERISATION IS REQUIRED FOR ANAESTHETISED OR UNCONSCIOUS
PATIENTS